Kentucky Opioid Policy: Mandating Physician Training
This policy analysis examines three legislative options available to Kentucky policymakers in response to the state's opioid epidemic, which claimed 1,404 overdose deaths in 2016 alone. The three options evaluated are: mandating physician training on pain management and safe prescribing practices, establishing a statewide Prescription Drug Monitoring Program (PDMP), and expanding access to the overdose-reversal drug naloxone. After weighing the pros and cons of each approach, the paper recommends mandatory prescribing training as the most effective intervention, arguing that it addresses the root cause of overprescribing. Strategies for mitigating the policy's drawbacks—including public education campaigns, adequate funding, and ongoing monitoring—are also discussed.
- Introduction: Kentucky's Opioid Crisis: Scope of Kentucky's opioid overdose problem
- Option 1: Mandate Additional Physician Training: Training requirements for safer opioid prescribing
- Option 2: Prescription Drug Monitoring Program (PDMP): Statewide database to track prescription patterns
- Option 3: Expand Access to Naloxone: Overdose-reversal drug availability as intervention
- Recommendation and Mitigating the Cons: Training mandate preferred; strategies to offset drawbacks
- Conclusion: Mandatory training as key to curbing epidemic
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper uses a clear options-analysis framework, presenting each policy alternative with explicit pros and cons before arriving at a reasoned recommendation — a structure well-suited to health policy writing.
- The recommendation is grounded in a logical argument: it targets the root cause (unsafe prescribing) rather than downstream consequences, distinguishing it meaningfully from the other two options.
- The "Mitigating the Cons" section demonstrates nuanced thinking by acknowledging the weaknesses of the chosen recommendation and proposing concrete solutions, strengthening the overall argument.
Key academic technique demonstrated
This paper demonstrates comparative policy analysis — a technique in which multiple policy options are systematically evaluated along the same evaluative dimensions (pros and cons) before a reasoned recommendation is issued. This approach shows readers not just what the author recommends, but why competing alternatives were found less compelling, lending credibility to the conclusion.
Structure breakdown
The paper opens by establishing the scope of the opioid crisis in Kentucky, then devotes a section to each of the three policy options, each with a description, pros, and cons. A recommendation section defends the preferred option against the alternatives and proposes mitigation strategies. A "Take Home Message" reinforces the policy imperative before a brief formal conclusion ties the argument together. References follow in APA format.
Introduction: Kentucky's Opioid Crisis
The current opioid epidemic in the United States has been labeled the worst drug crisis in American history. In 2015, over 33,000 people died from an opioid overdose, and the majority of those deaths were caused by prescription opioids. In Kentucky, opioids are a particularly severe problem, with 1,404 overdose deaths recorded in 2016. In response to this public health crisis, Kentucky policymakers have a variety of options available to them, each with distinct advantages and disadvantages.
Option 1: Mandate Additional Physician Training
One option is to pass legislation requiring physicians to complete a certain amount of training on pain management and safe prescribing practices before being allowed to prescribe opioids. The high number of overdoses is due in part to the fact that opioids are very easy to obtain. In Kentucky, there are no limits on the amount of opioids a physician can prescribe, and there is no mandatory training on pain management or safe prescribing practices. This lack of regulation has allowed physicians to prescribe large amounts of opioids without oversight, contributing to the current crisis.
Legislation requiring physicians to complete training on pain management and safe prescribing practices would help prevent future overdoses and save lives. The training would ensure that physicians are knowledgeable about the risks associated with opioids and how to prescribe them safely. It would also help create a system of accountability, so that physicians who prescribe large quantities of opioids can be identified and monitored.
Proponents of mandatory training argue that it is necessary in order to reduce the number of prescription drug overdoses and deaths. They contend that doctors need to be better educated on the risks associated with pain medications and how to safely prescribe them. Additional training could help doctors and nurses, in the long run, to save lives (Scrivani et al., 2021).
Opponents of mandatory training argue that it places an unnecessary burden on doctors, who are already required to complete a significant amount of continuing education. They also argue that such training would do little to reduce the number of overdoses and deaths, as most of these cases involve patients who misuse or abuse their medication.
Option 2: Prescription Drug Monitoring Program (PDMP)
A second option is to establish a statewide prescription drug monitoring program (PDMP) to track prescriptions and identify patterns of abuse. Currently, Kentucky is one of only a handful of states that does not have a statewide PDMP. A PDMP is a database that tracks prescriptions for controlled substances, such as painkillers (Fink et al., 2018). It can help identify patterns of abuse and assist pharmacists and physicians in making informed decisions about prescribing controlled substances. In addition, a PDMP can help prevent "doctor shopping," where patients visit multiple doctors to obtain multiple prescriptions for the same controlled substances (Young et al., 2019).
Establishing a statewide PDMP would benefit public health in Kentucky in several ways: it would help identify and track individuals who are abusing prescription drugs, help prevent doctor shopping and its associated costs (such as emergency room visits), and provide pharmacists and physicians with better tools for making informed prescribing decisions.
There are several potential benefits of PDMPs. First, they can help identify patients who are doctor shopping — that is, visiting multiple doctors to obtain multiple prescriptions for controlled substances. Second, they can help identify physicians who are prescribing controlled substances inappropriately. Third, they can help identify pharmacies that are dispensing unusually large quantities of controlled substances. Finally, PDMPs can be used to track changes in prescribing patterns over time, which is helpful in identifying trends in prescription drug abuse and determining where more attention is needed.
There are also some potential drawbacks to PDMPs. There is the potential for misuse of the data by unauthorized individuals. Additionally, the data collected by PDMPs may not always be accurate or complete. Finally, some have raised concerns about the confidentiality of the data collected by PDMPs. Despite these potential drawbacks, many states have implemented PDMPs in an effort to address the problem of prescription drug abuse.
Conclusion
The opioid epidemic in the United States has become a public health crisis, with the number of overdoses and deaths continuing to rise each year. One way to help stop this problem is to mandate that doctors and nurses undergo pain management training and safe prescribing practices training. By ensuring that those who prescribe opioids understand how to safely and effectively manage pain, we can help reduce the risk of prescription abuse and misuse. In addition, this training can help educate providers on the signs of addiction and how to refer patients to treatment if necessary. By mandating this training for all providers, we can help protect patients and prevent further devastation from this epidemic.
Fink, D. S., Schleimer, J. P., Sarvet, A., Grover, K. K., Delcher, C., Castillo-Carniglia, A., ... & Cerdá, M. (2018). Association between prescription drug monitoring programs and nonfatal and fatal drug overdoses: a systematic review. Annals of Internal Medicine, 168(11), 783–790.
Schnell, M., & Currie, J. (2018). Addressing the opioid epidemic: is there a role for physician education? American Journal of Health Economics, 4(3), 383–410.
Scrivani, S. J., Keith, D. A., Kulich, R. J., DaSilva, A. F., Donoff, R. B., Handa, S., ... & Schatman, M. E. (2021). Pain management for dental medicine in 2021: Opioids, coronavirus and beyond. Journal of Pain Research, 14, 1371.
Ti, L., Mihic, T., James, H., Shalansky, S., Legal, M., & Nolan, S. (2022). Implementation of an opioid stewardship program to promote safer opioid prescribing. The Canadian Journal of Hospital Pharmacy, 75(2), 113–117.
Young, S. G., Hayes, C. J., Aram, J., & Tait, M. A. (2019). Doctor hopping and doctor shopping for prescription opioids associated with increased odds of high-risk use. Pharmacoepidemiology and Drug Safety, 28(8), 1117–1124.
Always verify citation format against your institution’s current style guide requirements.